RVXCF (Resverlogix) FCF Yield % : -36.43 (As of Dec. 14, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Resverlogix FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Resverlogix's Trailing 12-Month Free Cash Flow is $-4.07 Mil, and Market Cap is $10.86 Mil. Therefore, Resverlogix's FCF Yield % for today is -36.43%.

The historical rank and industry rank for Resverlogix's FCF Yield % or its related term are showing as below:

RVXCF' s FCF Yield % Range Over the Past 10 Years
Min: -49.9 Med: 0 Max: 4.01
Current: -36.43

During the past 13 years, the highest FCF Yield % of Resverlogix was 4.01%. The lowest was -49.90%. And the median was 0.00%.

RVXCF's FCF Yield % is ranked worse than
69.87% of 1507 companies
in the Biotechnology industry
Industry Median: -12.96 vs RVXCF: -36.43

Resverlogix's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

Resverlogix FCF Yield % Historical Data

The historical data trend for Resverlogix's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resverlogix FCF Yield % Chart

Resverlogix Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-8.28

-14.04

-9.15

-14.73

-21.20

Resverlogix Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Yield %	Get a 7-Day Free Trial															-18.63	-21.70	-61.37	-32.23	-28.02

Competitive Comparison of Resverlogix's FCF Yield %

For the Biotechnology subindustry, Resverlogix's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Resverlogix's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Resverlogix's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Resverlogix's FCF Yield % falls into.

Resverlogix FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Resverlogix's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-3.061	/	14.435663
	=	-21.20%

Resverlogix's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.721	*	4	/	10.29434
	=	-28.02%

Resverlogix FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Resverlogix FCF Yield % Related Terms

Thank you for viewing the detailed overview of Resverlogix's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Resverlogix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Resverlogix Corp (OTCPK:RVXCF) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

0VF9:UK RFS:Germany RVX:Canada

Address

4820 Richard Road South West, Suite 300, Calgary, AB, CAN, T3E 6L1

Website

https://www.resverlogix.com

Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.